Search for the latest updates on diabetes
News
Boston Therapeutics Completes Enrollment of Patients With Type 2 Diabetes in Phase IIb Study on BTI-320 in the U.S. Marketwired via Yahoo! Finance - 59 minutes
MANCHESTER, NH--(Marketwired - Aug 20, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE), a developer of complex carbohydrate therapeutics to ...
Manage alerts · Unsubscribe · Privacy Policy
Tip: To search for an exact phrase, put quotation marks around two or more words.
| You received this email because you subscribed to Yahoo! Alerts. |
No comments:
Post a Comment